Abstract Details

Title Patient Satisfaction of Teleneurology during COVID-19 Pandemic in Detroit

Topic Practice, Policy, and Ethics

Presentation(s) P18 - Poster Session 18 (5:30 PM-6:30 PM)

Poster/Presentation
Number 1-001

Objective Assess patient satisfaction of telemedicine implementation during the COVID-19 pandemic

Background We aimed to learn neurology clinic patient opinions of a new telemedicine clinic during the COVID-19 pandemic in an urban academic center.

Design/Methods We conducted surveys on neurology clinic patients or caregivers with consent who had ≥ 1 telemedicine visit during the COVID-19 pandemic. The patient survey was adapted, with permission, on the Massachusetts General Hospital TeleHealth Virtual Visit Patient survey and responses were managed using REDCap database.

Results Forty-one patient surveys were completed, of which 52.6% of responders were Black, and 65.8% were women. Over 55% of patients were 18-45 years old. Fifty-eight percent of patients had education beyond a high-school diploma. Sixty-five percent of patients had their first telemedicine visit during the pandemic and most of them were at home (97%). Fifty-nine percent used smart phones, 25.6% had a cell phone without video capacity, and 92.1% used their own device. Wi-Fi was used by 67.6% and 27% used cellular network data. Twenty-five percent of patients experienced some technical issues and over 50% was specifically with joining a video visit. Despite the technical issues, more than 75% of patients reported that they still received the care they needed. Overall positive rating was 67.5%. Four patients strongly disliked telemedicine. Eighty-seven percent reported their virtual visit is as effective as a traditional office visit in communicating their needs. Compared to virtual visit, 49% of patients felt more confident that an office visit would address their health concern better. Fifty percent of patients reported that an office visit had better overall quality. Eighty-three percent would recommend a virtual visit to their family and friends.

Conclusions Our study demonstrated telemedicine has received high overall patient satisfaction in an urban-based neurology clinic. More surveys need to be completed to determine clinical significance.

Authors/Disclosures
Bowen Song, MD PRESENTER	Dr. Song has nothing to disclose.
Deepti Zutshi, MD, FAAN (Wayne State University School of Medicine)	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Maryam J. Syed, MBBS (Wayne State University School of Medicine)	Dr. Syed has nothing to disclose.
Rohit A. Marawar, MD, FAAN (Wayne State University - Detroit Medical Center)	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Maysaa M. Basha, MD, FAAN (Wayne State University, Detroit Medical Center)	Dr. Basha has nothing to disclose.
Janaki Patel, MD	Dr. Patel has nothing to disclose.
Arshdeep Kaur, MD (Detroit Medical Centre)	Dr. Kaur has nothing to disclose.

��ɫ��

��ɫ��